[1] |
Jemal A,Siegel R,Xu J, et al.Cancer statistics, 2010.CA Cancer J Clin, 2010, 60(5): 277-300.
|
[2] |
Yang L,Parkin DM,Li L, et al.Time trends in cancer mortality in China:1987-1999.Int J Cancer, 2003, 106(5): 771-783.
|
[3] |
Lapidot T,Sirard C,Vormoor J et al.A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.Nature, 1994, 367(6464): 645-648.
|
[4] |
Dick JE.Stem cell concepts renew cancer research.Blood, 2008, 112(13): 4793-4807.
|
[5] |
Al-Hajj M,Wicha MS,Benito-Hernandez A, et al.Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci USA, 2003, 100(7): 3983-3988.
|
[6] |
Singh SK,Hawkins C,Clarke ID, et al.Identification of human brain tumour initiating cells.Nature, 2004, 432(7015): 396-401.
|
[7] |
Richardson GD,Robson CN,Lang SH, et al.CD133, a novel marker for human prostatic epithelial stem cells.J Cell Sci, 2004, 117(Pt16): 3539-3545.
|
[8] |
Seigel GM,Campbell LM,Narayan M, et al.Cancer stem cell characteristics in retinoblastoma.Mol Vis, 2005, 11: 729-737.
|
[9] |
Kim CF,Jackson EL,Woolfenden AE, et al.Identification of bronchioal veolar stem cells in normal lung and lung cancer.Cell, 2005, 121(6): 823-835.
|
[10] |
Fang D,Nguyen TK,Leishear K, et al.A tumorigenic subpopulation with stem cell properties in melanomas.Cancer Res, 2005, 65(20): 9328-9337.
|
[11] |
Radtke F,Clevers H. Self-renewal and cancer of the gut:two sides of a coin.Science, 2005, 307(5717): 1904-1909.
|
[12] |
Morrison SJ,Kimble J. Asymmetric and symmetrics tem-cell divisions in development and cancer.Nature, 2006, 441(7097): 1068-1074.
|
[13] |
Segditsas S,Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway[J]. Oncogene, 2006, 25(57): 7531-7537.
|
[14] |
Boman BM,Wicha MS,Fields JZ, et al.Symmetric division of cancer stem cells-a key mechanism in tumor growth that should be targeted in future therapeutic approaches.Clin Pharmacol Ther, 2007, 81(6): 893-898.
|
[15] |
Boman BM,Fields JZ,Cavanaugh KL, et al.How dysregulated colonic crypt dynamics cause stem cell over population and initiate colon cancer.Cancer Res, 2008, 68(9): 3304-3313.
|
[16] |
Huang EH,Wicha MS.Colon cancer stem cells:implications for prevention and therapy.Trends Mol Med, 2008, 14(11): 503-509.
|
[17] |
Vaiopoulos AG,Kostakis ID,Koutsilieris M, et al.Colorectal cancer stem cells .Stem Cells, 2012, 30(3): 363-371.
|
[18] |
Ricci-Vitiani L,Lombardi DG,Pilozzi E, et al.Identification and expansion of human colon-cancer-initiating cells.Nature, 2007, 445(7123): 111-115.
|
[19] |
O'Brien CA,Pollett A,Gallinger S, et al.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.Nature, 2007, 445(7123): 106-110.
|
[20] |
Ieta K,Tanaka F,Haraguchi N, et al.Biological and genetic characteristics of tumor-initiating cells in coloncancer.Ann Surg Oncol, 2008, 15(2): 638-648.
|
[21] |
Shmelkov SV,Butler JM,Hooper AT, et al.CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.J Clin Invest, 2008, 118(6): 2111-2120.
|
[22] |
Dalerba P,Dylla SJ,Park IK, et al.Phenotypic characterization of human colorectal cancer stem cells.Proc Natl Acad Sci USA, 2007, 104(24): 10158-10163.
|
[23] |
Du L,Wang H,He L, et al.CD44 is of functional importance for colorectal cancer stem cells.Clin Cancer Res, 2008, 14(21): 6751-6760.
|
[24] |
Barker N,Van EJ,Kuipers J, et al.Identification of stem cells in small intestine and colon by marker gene Lgr5.Nature, 2007, 449(7165): 1003-1007.
|
[25] |
Sangiorgi E,Capecchi MR.Bmi1 is expressed in vivo in intestinal stem cells.Nat Genet, 2008, 40(7): 915-920.
|
[26] |
Boman BM,Huang E. Human colon cancer stem cells:a new paradigm in gastrointestinal oncology.J Clin Oncol, 2008, 26(17): 2828-2838.
|
[27] |
Medema JP,Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.Nature, 2011, 474(7351): 318-326.
|
[28] |
Vries RG,Huch M,Clevers H. Stem cells and cancer of the stomach and intestine.Mol Oncol, 2010, 4(5): 373-384.
|
[29] |
Todaro M,Francipane MG,Medema JP, et al.Colon cancer stem cells:promise of targeted therapy.Gastroenterology, 2010, 138(6): 2151-2162.
|
[30] |
Potten CS,Gandara R,Mahida YR, et al.The stem cells of small intestinal crypts:where are they? .Cell Prolif.2009, 42(6): 731-750.
|
[31] |
Burk U,Schubert J,Wellner U, et al.A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.EMBO Rep, 2008, 9(6): 582-589.
|
[32] |
Ginestier C,Hur MH,Charafe-Jauffret E, et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Cell Stem Cell, 2007, 1 (5) : 555-567.
|
[33] |
Hermann PC,Huber SL,Herrler T, et al.Distinct populations of cancer stem cells determine tumor growth and metastati cactivity inhuman pancreatic cancer.Cell Stem Cell, 2007, 1 (3): 313-323.
|
[34] |
Thiery JP.Epithelial-mesenchymal transitions in tumour progression .Nat Rev Cancer, 2002, 2(6): 442-454.
|
[35] |
Brabletz T,Jung A,Spaderna S, et al.Opinion:migrating cancer stem cells-an integrated concept of malignant tumour progression.Nat Rev Cancer, 2005, 5(9): 744-749.
|
[36] |
Lou H Dean M. Targeted therapy for cancers tem cells:the patched pathway and ABC transporters .Oncogene, 2007, 26(9): 1357-1360.
|
[37] |
Yu F,Yao H,Zhu P, et al.let-7 regulates selfrenewal and tumorigenicity of breast cancer cells.Cell, 2007, 131(6): 1109-1123.
|
[38] |
Subramaniam V,Vincent IR,Gilakjan M, et al.Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy.Exp Mol Pathol, 2007, 83(3): 332-340.
|
[39] |
Wen K,Fu Z,Wu X, et al.Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells:Effects associated with STAT3/Survivin .Cancer Lett, 2012.
|
[40] |
Frank NY,Schatton T,Frank MH.The therapeutic promise of the cancer stem cell concept .JClinInvest, 2010, 120(1): 41-50.
|
[41] |
Singh A,Settleman J. EMT, cancer stem cells and drug resistance:anemerging axis of evil in the war on cancer.Oncogene, 2010, 29(34): 4741-4751.
|